Sponsor:
Boston Children's Hospital
Code:
NCT00272883
Conditions
Central Core Disease
Centronuclear Myopathy
Congenital Fiber Type Disproportion
Multiminicore Disease
Myotubular Myopathy
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Central Core Disease
Centronuclear Myopathy
Congenital Fiber Type Disproportion
Multiminicore Disease
Myotubular Myopathy
Study ID
NCT00272883
Start date
Aug, 2003
Status verified date
Mar, 2026
Completion date
Jan, 2050
Anticipated
Primary completion date
Jan, 2050
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
4000 participants
Anticipated
Primary outcome measure
Central contacts
Beggs lab
beggslab@enders.tch.harvard.eduLocations
Genetics Division, Boston Children's Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Principal Investigator:
Alan H. Beggs, Ph.D.
Sponsor
Boston Children's Hospital
Last update posted
Mar 25, 2026
Last verified
Mar, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2026-03-25.